Go to content
UR Home

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

Munker, Stefan, Gerken, Michael, Fest, Petra, Ott, Claudia, Schnoy, Elisabeth, Fichtner-Feigl, Stefan, Wiggermann, Philipp, Vogelhuber, Martin, Herr, Wolfgang, Stroszczynski, Christian, Schlitt, Hans Jürgen, Evert, Matthias, Reng, Michael, Klinkhammer-Schalke, Monika and Teufel, Andreas (2018) Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects. BMC Cancer 18 (455), pp. 1-9.

[img]License: Creative Commons Attribution 4.0
PDF
Download (640kB)
Date of publication of this fulltext: 27 Sep 2018 17:16

at publisher (via DOI)

Other URL: http://doi.org/10.1186/s12885-018-4380-z


Abstract

Background 5-Fluorouracil (5FU), Folinic acid (FA), and Oxaliplatin (FOLFOX) or 5FU, FA, and Irinotecan (FOLFIRI) are standard regimens for palliative chemotherapy of metastatic colon cancer. Since data showing the influence of dose reduction in palliative treatment are rare, the objective of this single center, retrospective study was to further characterize the influence of dose reduction on ...

plus


Export bibliographical data



Item type:Article
Date:23 April 2018
Institutions:Medicine > Lehrstuhl für Röntgendiagnostik
Projects:Open Access Publizieren (DFG)
Identification Number:
ValueType
10.1186/s12885-018-4380-zDOI
Keywords:Dose reduction, Cancer, Colorectal cancer, Chemotherapy
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:37795
Owner only: item control page

Downloads

Downloads per month over past year

  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons